|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||11.00 - 11.00|
|52 Week Range||5.04 - 12.25|
|Beta (5Y Monthly)||1.43|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||0.59 (5.40%)|
|Ex-Dividend Date||Mar 27, 2020|
|1y Target Est||N/A|
Is (BVNRY) Outperforming Other Medical Stocks This Year?
BAVARIAN NORDIC (BVNRY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
Paul Chaplin has been the CEO of Bavarian Nordic A/S (CPH:BAVA) since 2014. This report will, first, examine the CEO...